Clinical Trial Update: A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

This is a randomized Phase 2 trial comparing Fruquintinib plus TAS-102 versus Fruquintinib alone in patients with refractory advanced/metastatic colorectal canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Fruquintinib (fruquintinib)
• TAS-102 (trifluridine/tipiracil)

Snippet

Sponsor: Criterium, Inc. | Conditions: Colorectal Cancer | Phase 2 | Status: RECRUITING